GL1X · GenesisL1 explorer

Research workbench

Structure of PLK1 kinase domain in complex with a benzolactam-derived inhibitor

Analyse Structure of PLK1 kinase domain in complex with a benzolactam-derived inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3THB
Type
protein
Length
287 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase PLK1
EC
2.7.11.21
UniProt
P53350
Ligands
3TA, ZN
Pockets
5 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase PLK1 (EC 2.7.11.21)protein28734% helix, 20% strandP53350

Ligands and binding sites

  • 3TA · 9-chloro-2-({5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl}amino)-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepine-6-thi one · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13940.710.82453TA
2680.500.8418empty
31250.470.7822empty
4940.370.7616empty
5510.290.7510empty

Compared structures

  • 3THB · Structure of PLK1 kinase domain in complex with a benzolactam-derived inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.